Changtao Jiang

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

Lulu Sun, Cen Xie, Guang Wang et al. · Nature Medicine · 2018 · 961 citations · Full text

Probiotic, Dysbiosis, Health Sciences +14

Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome

Xinyu Qi, Chuyu Yun, Lulu Sun et al. · Nature Medicine · 2019 · 791 citations · Full text

Inflammation, Mucosal Immunology, Immunology +5

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Fei Li, Changtao Jiang, Kristopher W. Krausz et al. · Nature Communications · 2013 · 681 citations · Full text

Obesity, Decreased Obesity, Dysbiosis +9

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Changtao Jiang, Cen Xie, Fei Li et al. · Journal of Clinical Investigation · 2014 · 655 citations · Full text

Gastroenterology, Pathology, Gut Microbiota +16

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

Changtao Jiang, Cen Xie, Ying Lv et al. · Nature Communications · 2015 · 529 citations · Full text